摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

apo-8,6'-carotendial

中文名称
——
中文别名
——
英文名称
apo-8,6'-carotendial
英文别名
(2E,4E,6E,8E,10E,12E,14E,16E)-2,6,11,15-tetramethyloctadeca-2,4,6,8,10,12,14,16-octaenedial;apo-8,6′-carotendial;6,8'-Diapocarotene-6,8'-dial
apo-8,6'-carotendial化学式
CAS
——
化学式
C22H26O2
mdl
——
分子量
322.447
InChiKey
HADDAGQXXLLFSE-VOSMWNACSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.2
  • 重原子数:
    24
  • 可旋转键数:
    9
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    34.1
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    番茄红素potassium permanganate十六烷基三甲基溴化铵 作用下, 以 二氯甲烷甲苯 为溶剂, 反应 1.0h, 生成 (2E,4E,6E)-3,7,11-trimethyldodeca-2,4,6,10-tetraenalapo-8,12'-carotendialapo-6,12'-carotendialapo-8,6'-carotendial 、 alkaline earth salt of/the/ methylsulfuric acid
    参考文献:
    名称:
    体外氧化产生的番茄红素裂解产物:表征和形成机理。
    摘要:
    这项研究的目的是生产番茄红素的体外氧化产物,这可能是体内代谢产物。番茄红素用高锰酸钾的氧化产生了一系列番茄红素降解化合物,这些化合物是由一个或两个碳-碳双键的氧化裂解产生的。获得了十一种载脂蛋白低碳脂蛋白/单糖和六种载脂蛋白-胡萝卜素,并通过HPLC-DAD-MS进行了初步鉴定。首次分离了载脂蛋白-11-冰醛和载脂蛋白8,6'-胡萝卜素,并通过(1)H NMR进行了表征。番茄红素受到金属卟啉催化的大气氧氧化,该金属卟啉是细胞色素P450酶活性中心的模型系统。形成(E)-番茄红素的(Z)-异构体,一氧化物和裂解化合物。我们提出了该系统氧化番茄红素的机理。
    DOI:
    10.1021/jf034735+
点击查看最新优质反应信息

文献信息

  • Fractionation and Characterization of Lycopene-Oxidation Products by LC-MS/MS (ESI)<sup>+</sup>: Elucidation of the Chemopreventative Potency of Oxidized Lycopene in Breast-Cancer Cell Lines
    作者:Bangalore Prabhashankar Arathi、Poorigali Raghavendra-Rao Sowmya、Gini Chempakathinal Kuriakose、Shivaprasad Shilpa、Hulikere Jagdish Shwetha、Sharath Kumar、Marisiddaiah Raju、Vallikannan Baskaran、Rangaswamy Lakshminarayana
    DOI:10.1021/acs.jafc.8b04850
    日期:2018.10.31
    Lycopene (LYC) has been correlated with the reduction of certain cancers and chronic diseases. However, the existence and biofunctionality of degraded, oxidized, and biotransformed LYC products in vivo have not been revealed. Therefore, this study aimed to screen and elucidate the potential bioactive lycopene-derived products in breast-cancer and noncancerous cells. LYC-oxidation or -cleavage products were generated using KMnO4. These oxidation products were separated as fractions I-III by silica column chromatography using gradient solvent systems. Further, LC-MS/MS (ESI)(+) was used to elucidate their possible fragmentation patterns and structures. Fraction II showed higher cytotoxicity (IC50 value of 64.5 mu M), cellular uptake, and apoptosis-inducing activity in MCF-7 cells. This fraction consists of major peak m/z 323, identified as apo-8,6'-carotendial. The cytotoxicity-inducing activity may be due to partial ROS generation with mitochondrial dysfunction. Further, the role of apo-8,6'-carotendial in the induction of apoptosis is demonstrated for the first time. These results illustrated that LYC-oxidation derivatives or metabolites are involved in growth inhibition of cancer cells. Exploration of specific oxidized-carotenoid products will give further insight into the field of nutritional biochemistry.
  • CAROTENOID OXIDATION PRODUCTS AS CHEMOPREVENTIVE AND CHEMOTHERAPEUTIC AGENTS
    申请人:Sharoni Yoav
    公开号:US20090069417A1
    公开(公告)日:2009-03-12
    The present invention relates to a method for the chemoprevention and treatment of cancer, by administering a pharmaceutical composition comprising a carotenoid derivative, such as a derivative of lycopene, a- and b-carotene, phytoene, phytofluene, lutein, zeaxanthin, α- and β-cryptoxanthin, canthaxanthin, astaxanthin, or other carotenoid. The carotenoid derivative is a carotenoid oxidation product, and is preferably an aldehyde derivative, a dialdehyde derivative or a ketone derivative. The carotenoid derivative can be a derivative of any naturally occurring carotenoid, such as those found in tomatoes and other fruits and vegetables.
  • [EN] CAROTENOID OXIDATION PRODUCTS AS CHEMOPREVENTIVE AND CHEMOTHERAPEUTIC AGENTS<br/>[FR] PRODUITS D'OXYDATION DES CAROTENOIDES UTILISES EN TANT QU'AGENTS CHIMIOPREVENTIFS ET CHIMIOTHERAPEUTIQUES
    申请人:LYCORED LTD
    公开号:WO2007043046A2
    公开(公告)日:2007-04-19
    [EN] The present invention relates to a method for the chemoprevention and treatment of cancer, by administering a pharmaceutical composition comprising a carotenoid derivative, e.g., a derivative of lycopene, a- and b-carotene, phytoene, phytofluene, lutein, zeaxanthin, a- and b-cryptoxanthin, canthaxanthin, astaxanthin, or other carotenoid. The carotenoid derivative is a carotenoid oxidation product, and is preferably an aldehyde derivative, a dialdehyde derivative or a ketone derivative. The carotenoid derivative can be a derivative of any naturally occurring carotenoid, e.g., carotenoids found in tomatoes and other fruits and vegetables.
    [FR] La présente invention concerne un procédé pour la chimioprévention et le traitement du cancer, par administration d'une composition pharmaceutique comprenant un dérivé de caroténoïde, par ex., un dérivé de lycopène, d'a- et ß-carotène, de phytoène, de phytofluène, de lutéine, de zéaxanthine, d'a- et ß-cryptoxanthine, de canthaxanthine, d'astaxanthine, ou d'autre caroténoïde. Le dérivé de caroténoïde est un produit d'oxydation des caroténoïdes et est de préférence un dérivé d'aldéhyde, un dérivé de dialdéhyde ou un dérivé de cétone. Le dérivé de caroténoïde peut être un dérivé de n'importe quel caroténoïde d'origine naturelle, par ex., des caroténoïdes trouvés dans les tomates et d'autres fruits et légumes.
  • Cleavage Products of Lycopene Produced by in Vitro Oxidations:  Characterization and Mechanisms of Formation
    作者:Catherine Caris-Veyrat、Antje Schmid、Michel Carail、Volker Böhm
    DOI:10.1021/jf034735+
    日期:2003.12.1
    The aim of this study was to produce in vitro oxidation products of lycopene, which could be possible in vivo metabolites. An oxidation of lycopene with potassium permanganate gave a range of lycopene degradation compounds resulting from the oxidative cleavage of one or two carbon-carbon double bonds. Eleven apo-lycopenals/ones and six apo-carotendials were obtained and tentatively characterized by
    这项研究的目的是生产番茄红素的体外氧化产物,这可能是体内代谢产物。番茄红素用高锰酸钾的氧化产生了一系列番茄红素降解化合物,这些化合物是由一个或两个碳-碳双键的氧化裂解产生的。获得了十一种载脂蛋白低碳脂蛋白/单糖和六种载脂蛋白-胡萝卜素,并通过HPLC-DAD-MS进行了初步鉴定。首次分离了载脂蛋白-11-冰醛和载脂蛋白8,6'-胡萝卜素,并通过(1)H NMR进行了表征。番茄红素受到金属卟啉催化的大气氧氧化,该金属卟啉是细胞色素P450酶活性中心的模型系统。形成(E)-番茄红素的(Z)-异构体,一氧化物和裂解化合物。我们提出了该系统氧化番茄红素的机理。
查看更多

同类化合物

(5β,6α,8α,10α,13α)-6-羟基-15-氧代黄-9(11),16-二烯-18-油酸 (3S,3aR,8aR)-3,8a-二羟基-5-异丙基-3,8-二甲基-2,3,3a,4,5,8a-六氢-1H-天青-6-酮 (2Z)-2-(羟甲基)丁-2-烯酸乙酯 (2S,4aR,6aR,7R,9S,10aS,10bR)-甲基9-(苯甲酰氧基)-2-(呋喃-3-基)-十二烷基-6a,10b-二甲基-4,10-dioxo-1H-苯并[f]异亚甲基-7-羧酸盐 (+)顺式,反式-脱落酸-d6 龙舌兰皂苷乙酯 龙脑香醇酮 龙脑烯醛 龙脑7-O-[Β-D-呋喃芹菜糖基-(1→6)]-Β-D-吡喃葡萄糖苷 龙牙楤木皂甙VII 龙吉甙元 齿孔醇 齐墩果醛 齐墩果酸苄酯 齐墩果酸甲酯 齐墩果酸乙酯 齐墩果酸3-O-alpha-L-吡喃鼠李糖基(1-3)-beta-D-吡喃木糖基(1-3)-alpha-L-吡喃鼠李糖基(1-2)-alpha-L-阿拉伯糖吡喃糖苷 齐墩果酸 beta-D-葡萄糖酯 齐墩果酸 beta-D-吡喃葡萄糖基酯 齐墩果酸 3-乙酸酯 齐墩果酸 3-O-beta-D-葡吡喃糖基 (1→2)-alpha-L-吡喃阿拉伯糖苷 齐墩果酸 齐墩果-12-烯-3b,6b-二醇 齐墩果-12-烯-3,24-二醇 齐墩果-12-烯-3,21,23-三醇,(3b,4b,21a)-(9CI) 齐墩果-12-烯-3,11-二酮 齐墩果-12-烯-2α,3β,28-三醇 齐墩果-12-烯-29-酸,3,22-二羟基-11-羰基-,g-内酯,(3b,20b,22b)- 齐墩果-12-烯-28-酸,3-[(6-脱氧-4-O-b-D-吡喃木糖基-a-L-吡喃鼠李糖基)氧代]-,(3b)-(9CI) 鼠特灵 鼠尾草酸醌 鼠尾草酸 鼠尾草酚酮 鼠尾草苦内脂 黑蚁素 黑蔓醇酯B 黑蔓醇酯A 黑蔓酮酯D 黑海常春藤皂苷A1 黑檀醇 黑果茜草萜 B 黑五味子酸 黏黴酮 黏帚霉酸 黄黄质 黄钟花醌 黄质醛 黄褐毛忍冬皂苷A 黄蝉花素 黄蝉花定